Mixed lineage kinase inhibitors and method of treatments

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9370515
APP PUB NO 20140256733A1
SERIAL NO

14201673

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are imidazopyridine compounds having an inhibitory effect on mixed lineage kinases (MLKs), methods of their synthesis, and methods of their therapeutic. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE BOX URV ROCHESTER NY 14642

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gelbard, Harris A Pittsford, US 14 68
Goodfellow, Val S Encinitas, US 13 200
Nguyen, Thong X San Diego, US 2 4
Ravula, Satheesh B San Diego, US 12 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00